glp 1 lower triglycerides Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature The mechanism of action of

The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study

In addition to reductions in binge-related behaviors, emotional eating a tendency to eat in response to negative emotions was moderately decreased among those treated with GLP-1RAs

Open Medicine, 18 (1), Article 20230692

Control of receptor trafficking might therefore be a useful strategy to enable sustained signaling, with significant implications for drug development 7

The HIV-1 Tat protein induces oxidative stress in B cells via mtROS production